Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2840
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Dipeptidyl peptidase-4 inhibitor linagliptin attenuates neointima formation after vascular injury ; volume:13 ; number:1 ; day:19 ; month:11 ; year:2014 ; pages:1-8 ; date:12.2014
Cardiovascular diabetology ; 13, Heft 1 (19.11.2014), 1-8, 12.2014
- Urheber
-
Terawaki, Yuichi
Nomiyama, Takashi
Kawanami, Takako
Hamaguchi, Yuriko
Takahashi, Hiroyuki
Tanaka, Tomoko
Murase, Kunitaka
Nagaishi, Ryoko
Tanabe, Makito
Yanase, Toshihiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12933-014-0154-3
- URN
-
urn:nbn:de:101:1-2021082219245036882252
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Terawaki, Yuichi
- Nomiyama, Takashi
- Kawanami, Takako
- Hamaguchi, Yuriko
- Takahashi, Hiroyuki
- Tanaka, Tomoko
- Murase, Kunitaka
- Nagaishi, Ryoko
- Tanabe, Makito
- Yanase, Toshihiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice
Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis
Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
Renal effects of the dipeptidyl peptidase inhibitor linagliptin in non-diabetic rats with 5/6 nephrectomy
Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation
Dipeptidyl peptidase IV : general and applied aspects
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie
Angioedema associated with dipeptidyl peptidase-IV inhibitors
Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice
Beiträge zur kinetischen Charakterisierung der Dipeptidyl-Peptidase IV
Development of dipeptidyl peptidase 8 and 9 inhibitors
Population pharmacokinetic and pharmacodynamic modelling and simulation of linagliptin, a novel dipeptidyl-peptidase 4 inhibitor for the treatment of type 2 diabetes
Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice
Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis
Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
Renal effects of the dipeptidyl peptidase inhibitor linagliptin in non-diabetic rats with 5/6 nephrectomy
Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation
Dipeptidyl peptidase IV : general and applied aspects
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie
Angioedema associated with dipeptidyl peptidase-IV inhibitors
Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice
Beiträge zur kinetischen Charakterisierung der Dipeptidyl-Peptidase IV
Development of dipeptidyl peptidase 8 and 9 inhibitors
Population pharmacokinetic and pharmacodynamic modelling and simulation of linagliptin, a novel dipeptidyl-peptidase 4 inhibitor for the treatment of type 2 diabetes
Dipeptidyl peptidase-4 inhibition with linagliptin prevents western diet-induced vascular abnormalities in female mice
Efficacy of dipeptidyl peptidase-4 inhibitor linagliptin in patients with type 2 diabetes undergoing hemodialysis
Dipeptidyl peptidase IV inhibitor attenuates kidney injury in rat remnant kidney
Renal effects of the dipeptidyl peptidase inhibitor linagliptin in non-diabetic rats with 5/6 nephrectomy
Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation
Dipeptidyl peptidase IV : general and applied aspects
Dipeptidyl-Peptidase IV : Biochemie, Physiologie u. Pathobiochemie
Angioedema associated with dipeptidyl peptidase-IV inhibitors
Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice
Beiträge zur kinetischen Charakterisierung der Dipeptidyl-Peptidase IV
Development of dipeptidyl peptidase 8 and 9 inhibitors